Starboard Value’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,473,971
Closed -$81.3M 108
2022
Q4
$81.3M Sell
5,473,971
-441,029
-7% -$7.2M 1.56% 16
2022
Q3
$97.7M Hold
5,915,000
2.15% 13
2022
Q2
$124M Hold
5,915,000
2.26% 15
2022
Q1
$139M Hold
5,915,000
1.84% 22
2021
Q4
$161M Hold
5,915,000
2.23% 19
2021
Q3
$168M Sell
5,915,000
-2,535,000
-30% -$77.2M 3.08% 16
2021
Q2
$255M Hold
8,450,000
5% 10
2021
Q1
$215M Hold
8,450,000
4.59% 12
2020
Q4
$207M Hold
8,450,000
5.27% 9
2020
Q3
$138M Hold
8,450,000
4.08% 12
2020
Q2
$144M Buy
8,450,000
+560,000
+7% +$8.3M 5.15% 10
2020
Q1
$91.8M Buy
7,890,000
+4,010,000
+103% +$82.7M 3.72% 12
2019
Q4
$108M Buy
+3,880,000
New +$97.3M 3.12% 11

Other funds holding MD

Starboard Value's MD Position: Q1 2023 in Review

Starboard Value sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 5,473,971 shares — an estimated $81.3M sold.

Starboard Value first reported a position in MD in Q4 2019 and held it in 13 quarters. The position peaked at $255M in Q2 2021. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

  • Starboard Value reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
  • Starboard Value sold 5,473,971 Pediatrix Medical shares in Q1 2023, an estimated $81.3M.
  • Starboard Value first reported a position in Pediatrix Medical in Q4 2019 and held it in 13 quarters.
  • Starboard Value's Pediatrix Medical position peaked at $255M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on Starboard Value's 13F filing for Q1 2023, filed 12 May 2023.